| ELISA kit stock availability: |
Available In Stock |
| ELISA's description: |
Human Neuroligin 2 (NLGN2) Control/blocking peptide |
| Category: |
Antibody Blocking Peptide |
| S type: |
Synthetic peptide (inquire immunogen) |
| Antibody's host is: |
see techfile |
| Purification: |
Affinity purified |
| Properties: |
Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Human proteins, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine, , (Homo sapiens, Homo sapiens sapiens), blocking peptide, humans , ssp |
| Description: |
, The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs, The shortest peptides are dipeptides, These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), and unbranched synthetic peptide chains, consisting of 2 amino acids joined by a single peptide bond, continuous, followed by tripeptides, or in continue produced for custom peptide synthesis projects, tetra peptides, till polypeptides that are long, Peptides short amino acid chains or epitopes or blocking antagonists |
| Gene target: |
Neuroligin 2 (NLGN2) / |
| Short name: |
Neuroligin 2 (NLGN2) Control/blocking peptide |
| Technique: |
For western blot it is often requested to block your antibody and to see the band of the analyzed protein disappear, This is called a negative control by blocking the WB antibody, adi made this blocking amino acid sequence or peptide to block the gene target in a volume of 1, controls, peptides, blocking peptide |
| Species: |
Humans, Human |
| Alternative name: |
sapiens Neuroligin 2 (neuroligin 2) reference/inhibiting short protein sequence, H |
| Alternative technique: |
controls |
| Alternative to gene target: |
Cell surfaces, GABAergic and biological process this GO :0035418 and protein localization to synapse and biological process this GO :0035641 and locomotory exploration behavior and biological process this GO :0042043 and neurexin family protein binding and molecular function this GO :0042734 and presynaptic membrane and cellular component this GO :0045202 and synapse and cellular component this GO :0045211 and postsynaptic membrane and cellular component this GO :0045217 and cell-cell junction maintenance and biological process this GO :0050804 and regulation of synaptic transmission and biological process this GO :0050808 and synapse organization and biological process this GO :0050839 and cell adhesion molecule binding and molecular function this GO :0050885 and neuromuscular process controlling balance and biological process this GO :0051965 and positive regulation of synapse assembly and biological process this GO :0051968 and positive regulation of synaptic transmission, NLGN2 and IDBG-24850 and ENSG00000169992 and 57555, NLGN2 and IDBG-634885 and ENSBTAG00000020252 and 787986, Nlgn2 and IDBG-192156 and ENSMUSG00000051790 and 216856, cell adhesion molecule binding, glutamatergic and biological process this GO :0060077 and inhibitory synapse and cellular component this GO :0072553 and terminal button organization and biological process this GO :0097104 and postsynaptic membrane assembly and biological process this GO :0097105 and presynaptic membrane assembly and biological process this GO :0097116 and gephyrin clustering and biological process this GO :0097119 and postsynaptic density protein 95 clustering and biological process this GO :0097151 and positive regulation of inhibitory postsynaptic membrane potential and biological process this GO :2000311 and regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity and biological process this GO :2000463 and positive regulation of excitatory postsynaptic membrane potential and biological process, this GO :0002087 and regulation of respiratory gaseous exchange by neurological system process and biological process this GO :0004872 and receptor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005887 and integral component of plasma membrane and cellular component this GO :0007158 and neuron cell-cell adhesion and biological process this GO :0007416 and synapse assembly and biological process this GO :0008152 and metabolic process and biological process this GO :0009986 and cell surface and cellular component this GO :0016020 and membrane and cellular component this GO :0016337 and single organismal cell-cell adhesion and biological process this GO :0016787 and hydrolase activity and molecular function this GO :0019233 and sensory perception of pain and biological process this GO :0030054 and cell junction and cellular component this GO :0032230 and positive regulation of synaptic transmission, this GO :0004872 : receptor activity, this GO :0004872 : receptor activity and also this GO :0005515 : protein binding and also this GO :0016787 : hydrolase activity and also this GO :0042043 : neurexin family protein binding and also this GO :0050839 : cell adhesion molecule binding, this GO :0005515 : protein binding, this GO :0016787 : hydrolase activity, this GO :0042043 : neurexin family protein binding, this GO :0050839 : cell adhesion molecule binding, neuroligin 2 |
| Identity: |
14290 |
| Gene: |
NLGN2 |
More about : NLGN2 |
| Long gene name: |
neuroligin 2 |
| Synonyms: |
KIAA1366 |
| Locus: |
17p13, 1 |
| Discovery year: |
2001-01-02 |
| GenBank acession: |
AB037787 |
| Entrez gene record: |
57555 |
| Pubmed identfication: |
10767552 10819331 |
| RefSeq identity: |
NM_020795 |
| Havana BLAST/BLAT: |
OTTHUMG00000108138 |